| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/19/2006 | US20060014245 Immunotoxins containing a cytotoxic RNAse fused to the N-terminus of one antibody variable domain prepared and retain the ability to specifically bind antigen; cancer |
| 01/19/2006 | US20060014244 Novel nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and ATPase-like molecules and uses therefor |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014241 Extended glucagon-like peptide-1 analogs |
| 01/19/2006 | US20060014226 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014217 Sphingomyelin detecting probe |
| 01/19/2006 | US20060014208 Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste |
| 01/19/2006 | US20060014200 Apparatus for analysis of a nucleic acid amplification reaction |
| 01/19/2006 | US20060014199 Molecular detection of chromosome aberrations |
| 01/19/2006 | US20060014183 Extendable probes |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014176 Reactor for chemical synthesis |
| 01/19/2006 | US20060014173 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/19/2006 | US20060014170 Detection without amplification and interference; measuring efficacy; packaged array can be used in robotic assembly for automated analysis |
| 01/19/2006 | US20060014166 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 01/19/2006 | US20060014162 As a target for drug development against Chagas' disease |
| 01/19/2006 | US20060014159 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 01/19/2006 | US20060014156 Nucleic acid detecting or quantifying processes |
| 01/19/2006 | US20060014153 Polypeptides as target for drugs to detect central nervous system disorders; cancer; metabolism; cardiovascular disorders |
| 01/19/2006 | US20060014152 Methods and reaction mixture reagent for increasing the specificity and fidelity of polymerase reactions |
| 01/19/2006 | US20060014144 Pseudonucleotide comprising an intercalator |
| 01/19/2006 | US20060014141 Method of detecting and quantifying cytomegalovirus |
| 01/19/2006 | US20060013829 Nucleic acid segments; coding zones; genetic engineered cells |
| 01/19/2006 | US20060013827 Method of diagnosing FIV |
| 01/19/2006 | US20060013824 RSV proteins, antibodies, compositions, methods and uses |
| 01/19/2006 | US20060013823 Administering LK6/68 proteins in which sequence is identical to apolipoprotein kringle domains to reduce tumor growth; recombinant Escherichia; for treatment of cancer, rheumatoid arthritis, and psoriasis |
| 01/19/2006 | US20060013822 Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines |
| 01/19/2006 | US20060013816 IgG4 constant region; Fab' fragment; antibody or antigen binding fragment inhibits binding of A2 or cA2 to human TNF- alpha , and binds to a neutralizing epitope of human TNF- alpha |
| 01/19/2006 | US20060013813 Proteins and nucleic acids encoding same |
| 01/19/2006 | DE10231659B4 Zusammensetzung zum Binden von Nukleinsäure an eine Festphase Composition for binding nucleic acid to a solid phase |
| 01/19/2006 | CA2838428A1 Compositions and methods for detection of hepatitis a virus nucleic acid |
| 01/18/2006 | EP1616942A2 Patched genes and their use |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616578A1 Compositions and methods for delivery of genetic material |
| 01/18/2006 | EP1616034A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 01/18/2006 | EP1615991A2 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
| 01/18/2006 | EP1615943A2 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2 |
| 01/18/2006 | EP1615942A2 Polymerase inhibitor and method of using same |
| 01/18/2006 | EP1615670A2 Targets for tumor growth inhibition |
| 01/18/2006 | EP1615612A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 01/18/2006 | EP1438424B1 Enzyme substrates for detecting beta-d-ribofuranosidase activity |
| 01/18/2006 | EP1097162B1 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/18/2006 | EP0815197B1 Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | CN1723217A Methods and compositions for analyzing compromised samples using single nucleotide polymorphism panels |
| 01/18/2006 | CN1721532A Clone of gene MAC30 related to pig backfat thickness and its use in mark-assisted selection |
| 01/18/2006 | CN1721428A Compound and method for treating cancer |
| 01/18/2006 | CN1237173C Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
| 01/18/2006 | CN1237172C Asia-africa hornet sedative peptide precursor gene and its coded polypeptide and preparing method |
| 01/18/2006 | CN1237073C Gene configuration, preparing process and usage of antibacterial peptide |
| 01/18/2006 | CN1237070C Biomolecule with therapeutic tumour action and its use |
| 01/17/2006 | US6987180 Nucleoside phosphate having 5-aminouracil group for incorporation into DNA via treatment with oxidizing agent or alkaline solution which cleaves position of unnatural nucleotide base; polymerase chain reactions |
| 01/17/2006 | US6987178 A recombinant expression vector; an isolated nucleic acid molecule; diagnosis of high blood pressure, obesity |
| 01/17/2006 | US6987177 Modified oligonucleotides, their preparation and their use |
| 01/17/2006 | US6987176 Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization |
| 01/17/2006 | US6987169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 01/17/2006 | US6987026 Vector for the transformation of Phaffia rhodozyma and process of transformation thereby |
| 01/17/2006 | US6987023 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987020 Full-gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
| 01/17/2006 | US6987016 α-galactosidases and methods for making and using them |
| 01/17/2006 | US6987013 NADH oxidase from lactobacillus |
| 01/17/2006 | US6987008 Mutant nucleoside-5'-phosphate-producing enzyme with ability for transphosphorylation activity and/or phosphatase activity; amino acid sequence with replacements elucidated; genes; recombinant DNA; microorganisms; crystals |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | US6987004 Discovery of four mammalian genes designated CalDAG-GEFI, CalDAG-GEFII, cAMP-GEFI, and cAMP-GEFII, which encode proteins having a substrate specificity for Rap1A; dual binding domains for calcium and diacylglycerol; anticarcinogenic agents |
| 01/17/2006 | US6987003 Modulation of RNA transport to the rough endoplasmic reticulum by staufen proteins; isolated nucleic acids encoding this protein and vectors and host cells expressing them; nucleic acid sequences and their encoded amino acid sequences; viricides |
| 01/17/2006 | US6987000 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); useful as modulating agents for regulating cardiac cellular differentiation/proliferation |
| 01/17/2006 | US6986989 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/17/2006 | US6986987 Genetic polymorphism in the receptor for IgA |
| 01/17/2006 | US6986985 Process for producing multiple nucleic acid copies in vivo using a protein-nucleic acid construct |
| 01/12/2006 | WO2006005032A2 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 01/12/2006 | WO2006004867A2 Mammalian endonucleases and methods of use |
| 01/12/2006 | WO2006004663A2 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/12/2006 | WO2005090606A3 Identification of toxic nucleotide sequences |
| 01/12/2006 | WO2005075655A3 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/12/2006 | WO2005047480A3 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
| 01/12/2006 | WO2005033662A3 Foreign pas ligands regulate pas domain function |
| 01/12/2006 | WO2005025495A3 Methods and compositions for blocking progression of a disease state |
| 01/12/2006 | WO2005021718A3 Tubulin regulatory elements for use in plants |
| 01/12/2006 | WO2005017128A3 Improved reagents for recombinogenic engineering and uses thereof |
| 01/12/2006 | WO2004090108A3 Irna conjugates |
| 01/12/2006 | WO2004031354A3 Human sarcoma-associated antigens |
| 01/12/2006 | US20060010518 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/12/2006 | US20060010516 Cell cycle genes and related methods |
| 01/12/2006 | US20060010511 Nobel glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthase and gene encoding it |
| 01/12/2006 | US20060010507 Endophilin III gene disruptions, compositions and methods related thereto |
| 01/12/2006 | US20060009634 Proteins and nucleic acids encoding same |
| 01/12/2006 | US20060009633 Complementary DNAs encoding proteins with signal peptides |
| 01/12/2006 | US20060009632 Nucleotide sequences coding metalloenzymes and/or aggrecanase for use in identifying modulators for prevention and treatment of bone disorders |
| 01/12/2006 | US20060009631 Nucleic acids encoding this enzyme; in humans, rodents; isotopes; purity; gene expression; transformation, translation of cells; sulfation of tyrosine; hybridization |
| 01/12/2006 | US20060009630 Composition for treating squamous cell carcinoma comprising an antibody that specifically binds a migration facilitating protein comprising a laminin 5 alpha 3 G4 and/or 5 domain or subdomain thereof, and a pharmaceutically acceptable carrier; treatment of skin cancer |
| 01/12/2006 | US20060009629 Organic light emitting device material and organic light emitting devcie |
| 01/12/2006 | US20060009628 CONTAINING A 3-SUBSTITUTED PYRRAZOLO(,3,4-d) PYRIMIDINE |
| 01/12/2006 | US20060009624 Phosphoramidites of substituted cyclic (cyclopentene, cyclohexene, and cyclohepene) bridged cyanine dyes, particularly those containing a N,N-diisopropyl-O- beta -cyanoethyl phosphoramidite group; preparation and use in labeling oligonucleotides, proteins and peptides |
| 01/12/2006 | US20060009441 Human trace amine associated receptors |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009408 siRNA-Mediated gene silencing with viral vectors |
| 01/12/2006 | US20060009405 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |